explore -WSS

explore

author：entertainment 2025-09-10 16:46:43 - browse：21237

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： How a Boston hospital is priming medical residents to use GPT

WSS

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Scientists grapple with ethics of stem cell research

Radiology is caught between AI's potential and concern for patients

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

After a decade, new Gardasil ad campaign gets it (mostly) right

Wikipedia

explore

entertainment

Affirmative action in medical school literally saved lives

Patients' immediate access to test results puts radiologists in a bind

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Delta passengers in Vegas fall sick while waiting on flight in triple

Duchenne breakthrough therapy leaves behind pioneering families

Leukemia patients are helped by Syndax's new type of therapy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Chemotherapy shortages won’t get better under Biden’s latest plan

Heart attack and stroke risk calculators need revising

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

leisure time

SCOTUS to consider access to abortion pill mifepristone

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Sanders wants to replace patents with prizes for drug inventions

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

FDA approves world's first CRISPR

Americans' trust in science, scientist continues decline: Report

focus

entertainment

focus

hotspot